TABLE 1.
Pharmacokinetic parameters describing the time course of concentrations of ciprofloxacin in plasma and compartments of the eyea
Compartment and parameterb | Initial estimate | Population mean | Coefficient of variationc | Distribution |
---|---|---|---|---|
Aqueous | ||||
Vc (liters) | 175 | 174 | 4 | Normal |
ka (h−1) | 1.99 | 2.06 | 39 | Normal |
t1/2a (h) | 0.35 | 0.34 | ||
kel (h−1) | 0.17 | 0.13 | 44 | Normal |
t1/2el (h) | 4.1 | 5.3 | ||
kpa · Vc/Va (h−1) | 0.052 | 0.045 | 14 | Log-normal |
kap (h−1) | 0.22 | 0.2 | 34 | Log-normal |
t1/2ap (h) | 3.2 | 3.5 | ||
K | 0.24 | 0.23 | ||
Vitreous | ||||
Vc (liters) | 175 | 171 | 4 | Normal |
ka (h−1) | 1.99 | 2.18 | 39 | Normal |
t1/2a (h) | 0.35 | 0.32 | ||
kel (h−1) | 0.17 | 0.14 | 39 | Normal |
t1/2el (h) | 4.1 | 4.9 | ||
kpv · Vc/Vvit (h−1) | 0.016 | 0.022 | 14 | Log-normal |
kvp (h−1) | 0.054 | 0.13 | 34 | Log-normal |
t1/2vp (h) | 13 | 5.3 | ||
K | 0.3 | 0.17 |
Half-lives corresponding to the rate constants of the model are shown.
t1/2a, half-life of absorption; t1/2el, half-life of elimination; t1/2ap, half-life of loss from the aqueous; t1/2vp, half-life of loss from the vitreous. The other abbreviations are defined in the text.
Intersubject variability expressed as percent coefficient of variation of the population.